Gujarat Alkalies & Chemicals delivered its highest-ever quarterly revenue in Q1 FY27, with standalone revenue rising 14% to ₹1,224.84 crore and consolidated revenue reaching ₹1,250 crore compared to ₹1,100 crore in the previous year. The company achieved a remarkable consolidated net profit of ₹550 crore versus a net loss of ₹138 crore in the corresponding quarter of the previous year, representing a complete financial turnaround. According to the company's unaudited financial results approved by the Board on July 23, 2026, this performance was driven by Profit Before Tax (PBT) surging 1,000% to ₹110 crore from ₹10 crore in the prior period, demonstrating exceptional operational efficiency and strategic initiatives.
The company's revenue from operations increased by ₹151.39 crore (14%) to ₹1,224.84 crore in Q1 FY27, compared to ₹1,073.45 crore recorded in the same quarter of the previous financial year. As reported by the company, this growth was fueled by optimizing product mix to increase realizations and expanding into new export markets. Managing Director Smt. Avantika Singh, IAS, highlighted that the revenue growth was driven by strategic initiatives to enhance product mix and diversify market presence, positioning the company for sustained growth in the chemical sector. The consolidated revenue stood at ₹1,250 crore versus ₹1,100 crore in Q1 FY26, demonstrating strong operational momentum across all business segments.
The company's EBITDA increased by ₹104 crore (83%) to ₹229 crore from ₹125 crore in Q1 FY26, with consolidated EBITDA margin expanding significantly to 17.70% from 10.55% in the prior year period. According to the financial data, this margin improvement was primarily attributed to reduced energy costs as the share of renewable power in the company's energy basket increased to 59% from 39% in the previous quarter. The company continues to drive efficiency through 'Project Ahvaan,' focusing on cost cutting, optimum capacity utilization, talent management, and digitization, supporting the Board's directive to expand green power usage while directly impacting the bottom line through lower energy expenses.
The Board approved in-principle approval for an additional Hydrochloric Acid (HCL) synthesis unit at Dahej with an approximate project cost of ₹55 crore. This unit aims to enhance chlorine utilization and optimize Caustic Soda production at the Dahej complex, with the additional HCL generated to be utilized in the Phosphoric Acid plant. The company also approved the 'Vision 2047' strategic document, aligning corporate strategy with the national vision of Viksit Bharat @2047. These strategic moves are part of a broader strategy to improve resource efficiency and diversify product offerings, positioning the company for long-term growth in the chemical industry while supporting India's net-zero carbon commitments through increased renewable energy adoption.
